| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200008)43:8<1663::AID-ANR1>3.0.CO;2-1 |
| P698 | PubMed publication ID | 10943854 |
| P2093 | author name string | Fazzini F | |
| Manfredi AA | |||
| Sabbadini MG | |||
| Rovere P | |||
| Rugarli C | |||
| Zimmermann VS | |||
| Bondanza A | |||
| P2860 | cites work | The induction of tolerance by dendritic cells that have captured apoptotic cells | Q24671078 |
| How can cryptic epitopes trigger autoimmunity? | Q24678950 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Structure and function of the pentraxins | Q28302580 | ||
| Rapid nucleolytic degradation of the small cytoplasmic Y RNAs during apoptosis | Q28371236 | ||
| Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes | Q28609747 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
| The role of phosphatidylserine in recognition of apoptotic cells by phagocytes | Q33592283 | ||
| Apoptosis: the importance of being eaten | Q33592289 | ||
| Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease | Q33592314 | ||
| The key role of nucleosomes in lupus | Q33633300 | ||
| The genes of systemic autoimmunity | Q33650380 | ||
| Developmental regulation of dendritic cell function | Q33664764 | ||
| Viruses, host responses, and autoimmunity | Q33713351 | ||
| Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis | Q33716988 | ||
| The role of apoptosis in systemic lupus erythematosus. | Q33787902 | ||
| Relation between infection and autoimmunity in mixed cryoglobulinemia | Q33824793 | ||
| Apoptosis in human autoimmune diseases | Q33836352 | ||
| CD14-dependent clearance of apoptotic cells: relevance to the immune system. | Q33840497 | ||
| Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. | Q33855405 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone | Q34255110 | ||
| Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response | Q35050844 | ||
| Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus | Q36361685 | ||
| Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes | Q36363024 | ||
| Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 | Q36364968 | ||
| CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
| Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity | Q36375304 | ||
| Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells | Q36375909 | ||
| Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease | Q36375982 | ||
| Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
| Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens | Q36400803 | ||
| CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells | Q36400881 | ||
| Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
| The central role of CD4(+) T cells in the antitumor immune response | Q36401381 | ||
| Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction | Q36401408 | ||
| Systemic exposure to irradiated apoptotic cells induces autoantibody production | Q36401434 | ||
| Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue | Q36404280 | ||
| Lethal effect of the anti-Fas antibody in mice | Q36696599 | ||
| A review on the biological properties of C-reactive protein | Q37449779 | ||
| Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus | Q37722431 | ||
| The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective | Q40387098 | ||
| Quantitation of precipitating antibodies to certain soluble nuclear antigens in sle | Q40647054 | ||
| The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein | Q40738906 | ||
| A vision of cell death: insights into immune privilege | Q40898578 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection | Q40907799 | ||
| Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies | Q40942556 | ||
| Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies | Q40997124 | ||
| Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
| Immunology of the antiphospholipid antibody syndrome | Q41116413 | ||
| Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis | Q41145666 | ||
| Recent developments in the understanding of antinuclear autoantibodies | Q41258667 | ||
| What triggers anti-dsDNA antibodies? | Q41438979 | ||
| Apoptosis in the rheumatic diseases | Q41640058 | ||
| Homeostasis and self-tolerance in the immune system: turning lymphocytes off. | Q41735900 | ||
| Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells | Q41834144 | ||
| Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia | Q42025177 | ||
| A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes | Q42039464 | ||
| Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus | Q43779444 | ||
| Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus | Q47849248 | ||
| Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens | Q47849301 | ||
| Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity | Q56595317 | ||
| Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies | Q57089602 | ||
| Immunosuppressive effects of apoptotic cells | Q59060221 | ||
| P433 | issue | 8 | |
| P921 | main subject | apoptotic process | Q14599311 |
| suicide prevention | Q3298118 | ||
| suicide | Q10737 | ||
| suicide risk | Q47319077 | ||
| P304 | page(s) | 1663-1672 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity | |
| P478 | volume | 43 |
| Q51052396 | Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. |
| Q36272782 | Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases |
| Q42964150 | Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells. |
| Q36535200 | Apoptosis and autoimmunity: when apoptotic cells break their silence. |
| Q44183286 | Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: lack of evidence for a direct role of lamin B1 in apoptotic blebs |
| Q43627126 | Atorvastatin-induced dermatomyositis |
| Q28218204 | Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders |
| Q40650525 | Caspase-mediated cleavage of the U snRNP-associated Sm-F protein during apoptosis. |
| Q47675146 | Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases. |
| Q36371130 | Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase |
| Q36699918 | Dendritic cells and cytokines in human inflammatory and autoimmune diseases |
| Q36370588 | Directing autoimmunity to nucleoprotein particles: the impact of dendritic cells and interferon alpha in lupus |
| Q36566594 | Endometriosis, a disease of the macrophage |
| Q37575071 | Epigenetic histone code and autoimmunity |
| Q24800835 | Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis |
| Q31022558 | Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1). |
| Q44250397 | Induction of cell death by sera from patients with acute brain injury as a mechanism of production of autoantibodies. |
| Q50769799 | Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse. |
| Q38194575 | Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. |
| Q36701020 | Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review |
| Q44876214 | Lupus-like syndrome associated with statin therapy |
| Q34106947 | PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation |
| Q84923118 | Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis |
| Q52655916 | Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models. |
| Q37103259 | Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. |
| Q43800695 | Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity |
| Q33950104 | Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells |
| Q64882605 | The Role of Efferocytosis in Autoimmune Diseases. |
| Q37030639 | The genetics and biology of Irf5-mediated signaling in lupus |
| Q39961855 | The immune reaction against allogeneic necrotic cells is reduced in Annexin A5 knock out mice whose macrophages display an anti-inflammatory phenotype. |
| Q34680879 | The neuropathology and pathogenesis of systemic lupus erythematosus |
| Q79788888 | [Autoimmune diseases and statins] |
| Q40728434 | beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways |
Search more.